Hegidron 500 Injection contains Hydroxyprogesterone 500mg, a synthetic progestogen used primarily in the management of various gynecological and obstetric conditions. This medication is indicated for the prevention of preterm birth in pregnant women with a history of spontaneous preterm delivery, as it helps maintain uterine quiescence by mimicking the natural hormone progesterone. Additionally, Hegidron 500 is employed in the treatment of secondary amenorrhea, abnormal uterine bleeding due to hormonal imbalance, and as part of hormone replacement therapy in certain clinical scenarios. The injection is administered intramuscularly, allowing for sustained release and prolonged therapeutic effect. Hydroxyprogesterone acts by modulating the endometrial lining and suppressing uterine contractions, thereby supporting pregnancy maintenance and regulating menstrual cycles. Careful patient evaluation is essential before initiating therapy, particularly in individuals with a history of thromboembolic disorders, liver dysfunction, or hypersensitivity to progestogens. Common adverse effects may include injection site reactions, headache, dizziness, and gastrointestinal disturbances. Hegidron 500 Injection should be used under strict medical supervision, with dosing tailored to the specific indication and patient response to optimize efficacy and minimize potential risks.